Outcomes and cost comparison of three therapeutic approaches to allergic rhinitis

American Journal of Rhinology and Allergy

Volumn 25, Issue 4, 2011, Pages 257-262

  Fairchild, Carol J ^a   Durden, Emily ^b   Cao, Zhun ^b   Smale, Patrick ^a  

^a ALCON RESEARCH LTD   (United States)

^b THOMSON REUTERS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; BRONCHODILATING AGENT; STEROID;

ADOLESCENT; ADULT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; CHRONIC OBSTRUCTIVE LUNG DISEASE; COST BENEFIT ANALYSIS; DRUG COST; FEMALE; FOLLOW UP; HEALTH CARE COST; HEALTH CARE UTILIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; PATIENT SATISFACTION; PREDICTOR VARIABLE; PRESCRIPTION; RESPIRATORY TRACT INFECTION; RETROSPECTIVE STUDY; STEROID THERAPY; TREATMENT OUTCOME;

ADMINISTRATION, INTRANASAL; COHORT STUDIES; DRUG THERAPY, COMBINATION; FEMALE; FOLLOW-UP STUDIES; HEALTH CARE COSTS; HISTAMINE ANTAGONISTS; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; RETROSPECTIVE STUDIES; RHINITIS, ALLERGIC, PERENNIAL; RHINITIS, ALLERGIC, SEASONAL; STEROIDS;

EID: 79960464129     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2011.25.3636     Document Type: Article

References (26)

1. Bukstein, D. The Obama dilemma: Allergic rhinitis (animal dander allergy) - The great burden of illness. Allergy Asthma Proc 30:567-572, 2009.
2. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63(suppl 86):8-160, 2008.
3. van Cauwenberge P, and van Hoecke H. Management of allergic rhinitis. B-ENT Suppl 1:45-62, 2005.
4. Bernstein JA. Allergic and mixed rhinitis: Epidemiology and natural history. Allergy Asthma Proc 31:365-369, 2010.
5. Settipane RA, and Charnock DR. Epidemiology of rhinitis: Allergic and nonallergic. Clin Allergy Immunol 19:23-34, 2007.
6. Bauchau V, and Durham SR. Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy 60:350-353, 2005. (Pubitemid 40293352)
7. Bousquet J, van CP, and Khaltaev N. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108:S147-S334, 2001.
8. Baroody FM. Allergic rhinitis: Broader disease effects and implications for management. Otolaryngol Head Neck Surg 128:616-631, 2003. (Pubitemid 41123124)
9. Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: An updated practice parameter. J Allergy Clin Immunol 122:S1-S84, 2008. (Pubitemid 352033573)
10. Bousquet J, Bullinger M, Fayol C, et al. Assessment of quality of life in patients with perennial allergic rhinitis with the French version of the SF-36 Health Status Questionnaire. J Allergy Clin Immunol 94: 182-188, 1994.
11. Meltzer EO, Casale TB, Nathan RA, et al. Once-daily fexofenadine HCl improves quality of life and reduces work and activity impairment in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol 83:311-317, 1999. (Pubitemid 29503666)
12. Kaliner MA, Storms W, Tilles S, et al. Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis. Allergy Asthma Proc 30:255-262, 2009.
13. Kivisaari E, Baker RC, and Price MJ. Comparison of once daily fluticasone propionate aqueous nasal spray with once daily budesonide reservoir powder device in patients with perennial rhinitis. Clin Exp Allergy 31:855-863, 2001.
14. Blaiss MS. Allergic rhinitis: Direct and indirect costs. Allergy Asthma Proc 31:375-380, 2010.
15. Barr CE, Schulman K, Iacuzio D, et al. Effect of oseltamivir on the risk of pneumonia and use of health care services in children with clinically diagnosed influenza. Curr Med Res Opin 23:523-531, 2007. (Pubitemid 46456900)
16. Berndt ER, Bir A, Busch SH, et al. The medical treatment of depression, 1991-1996: Productive inefficiency, expected outcome variations, and price indexes. J Health Econ 21:373-396, 2002.
17. Bridges CB, Thompson WW, Meltzer MI, et al. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA 284:1655-1663, 2000.
18. Lobo FS, Wagner S, Gross CR, et al. Addressing the issue of channeling bias in observational studies with propensity scores analysis. Res Soc Adm Pharm 2:143-151, 2006. (Pubitemid 44144470)
19. Curtis LH, Hammill BG, Eisenstein EL, et al. Using inverse probability- weighted estimators in comparative effectiveness analyses with observational databases. Med Care 45:S103-S107, 2007.
20. Hirano K, and Imbens G. Estimation of causal effects using propensity score weighting: An application to data on right heart catheterization. Health Serv Outcomes Res Methodol 2:259-278. 2001.
21. Rosebaum PR, and Rubin DB. Constructing a control-group using multivariate matched sampling methods that incorporate the propensity score. Amer Statist 39:33-38, 1985.
22. Gliklich RE, and Dreyer NA. Registries for evaluating patient outcomes: A user's guide. 2nd edition, Gliklich RE, and Dreyer NA (Senior Eds.). Rockville MD: Agency for Healthcare Research and Quality. 2010. Publication No. 10-EHC049.
23. Executive Summary: Adult, Allergy in America: A landmark survey of nasal allergy sufferers. 25-26, 2006. Available online at www.mmcpub.com/scsaia/adult. pdf; last accessed October 2010.
24. Dalal AA, Stanford R, Henry H, et al. Economic burden of rhinitis in managed care: A retrospective claims data analysis. Ann Allergy Asthma Immunol 101:23-29, 2008. (Pubitemid 352000740)
25. Zimnerman T. Medicinal therapy for glaucoma. In The Gluacomas: Concepts and Fundamentals. Eid TM and Spaeth GL (Eds). Philadelphia, PA: Lippincott Williams & Wilkins, 227-245, 2000.
26. National Heart, Lung and Blood Institute. Morbidity and mortality: 2004 Chartbook on cardiovascular, lung and blood diseases. Washington DC: U.S. Department of Health and Human Services. 2004.